| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.57 | 0.0005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |